← Back to the library
AnxietyJune 25, 2023 · 4 min read

Memantine For Anxiety and Depression - a New Treatment?

Memantine for Anxiety and Depression

Memantine for anxiety and depression with generic tablets and a blue-violet scientific motif

Memantine for Anxiety and Depression

Memantine, sold under the brand name Namenda, is classified as an anti-Alzheimer's drug. Memantine was first created in 1968 by the pharmaceutical company Eli Lily. It was developed as an antidiabetic medication but failed to lower blood sugar. Later it was discovered that it had actions in the nervous system and could be used to treat dementia. It was first marketed in 1989 in Germany as a treatment for dementia.

Mechanism of Action

Memantine has several notable actions in the central nervous system. First, it acts as an NMDA receptor antagonist. Second, it acts as an antagonist (blocker) of the 5-HT3 receptor. This serotonin receptor that when blocked relieves nausea. Third, it acts as an agonist of the D2 dopamine receptor. Though its affinity for the D2 receptor is small. This means that its action here may be negligible. For this article's purposes, we will focus on Memantines NMDA blocking action.

Action Similar to Ketamine

Ketamine is a drug found to have significant implication in the treatment of depression. It has historically been used as an anesthetic drug. In recent years it has been found to rapidly relieve the symptoms of depression. This is done through doses much smaller than the ones used for anesthesia. The antidepressant effects of Ketamine are also long lasting and may last up to weeks from a single dose. Memantine has a similar mechanism of action. Ketamine and Memantine both work as blockers of the NMDA receptor. Logic would dictate that if they both block the NMDA receptor (Ketamine's antidepressant effect is attributed to this action) they both may relieve depression.

Evidence of Memantines Use for Depression

One study reports on Memantines potential effectiveness for a multitude of psychiatric disorders: “Memantine monotherapy was found to exert efficacy in several neuropsychiatric conditions, including autism spectrum disorder, binge eating disorder, and attention-deficit/hyperactivity disorder. For posttraumatic stress disorder and generalized anxiety disorder, memantine was found efficacious in augmentation with other medications. In obsessive-compulsive disorder (OCD), memantine was used as both an augmentation to selective serotonin reuptake inhibitors and standalone therapy, and most published studies found it to improve OCD symptoms. For schizophrenia, memantine has been reported to be consistently effective for negative symptoms only. The manic phase of bipolar disorder also appears to benefit from memantine. The depressive phase of bipolar disorder and major depressive disorder did not respond significantly to memantine. Catatonia as a symptom of various disorders improved in several case studies when memantine was used in combination with other medications.”

https://pubmed.ncbi.nlm.nih.gov/30028898/

Another study concludes: “The NMDA receptor antagonist memantine may be an effective augmentation therapy in patients with treatment-resistant anxiety.”

https://pubmed.ncbi.nlm.nih.gov/22937414/

A third study states: “Memantine as an adjunct treatment appears to have significant efficacy in improving negative symptoms in schizophrenia. The efficacy and safety of adjunctive memantine for bipolar disorder or MDD (Major Depressive Disorder) needs to be further examined.”

https://pubmed.ncbi.nlm.nih.gov/31164254/

Side Effects and Basic Info

Memantine is pharmacologically classified as an NMDA receptor antagonist (blocker). It is available in capsule dosages of 7mg, 14mg, 21mg, and 28mg. It is also available in tablets of 5mg and 10mg. It has a half-life of 60-80 hours. It has various side effects such as arthralgia (joint pain), weight gain or loss, incontinence, diarrhea, vomiting, nausea, anxiety, agitation, depression, dizziness, fatigue, among others.

The Anxious Resistance Take on Namenda for Anxiety

Memantine shows a lot of potential. It has some major benefits over Ketamine therapy, although it has a similar action. It is tablet or capsule form and can be taken by mouth. Unlike Ketamine, which must be administered through an IV infusion. Memantine shows potential in its mechanism of action alone, although the studies listed above further prove that it may be an effective treatment for anxiety and depression. Memantine has more evidence behind it than some other off-label treatments. Memantine has not gained popularity with psychiatrists yet. More anecdotal and firsthand experiences may go a long way toward increasing the popularity of its use. It is our opinion that Memantine could be used as a third line treatment for those that have failed SSRIs (Selective Serotonin Reuptake Inhibitor) and other antidepressant categories such as the SNRIs (Serotonin Norepinephrine Reuptake Inhibitor) (Serotonin Norepinephrine Reuptake Inhibitor) and tricyclics, as well as combination therapies with Atypical Antipsychotics. Memantine may be something worth talking to your doctor about. They may be hesitant to prescribe but it could go a long way if you show them the current research on Memantines use in this way.

Discover the Secret: Can Namenda Unlock Mental Wellness?

Watch on YouTube

Educational content—not medical advice.Find support resources →